Table 1.
Number of dermal neurofibroma | Internal tumor (PNF) (volume in cm3) | ||||||||
---|---|---|---|---|---|---|---|---|---|
Patient no | Sex | Age | Subcutaneous | Cutaneous | None* | Low 1–99 cm3 | Medium 100–500 cm3 | High >500 cm3 | MPNST |
1 | M | 22 | 1 | 11–50 | x | ||||
2 | F | 40 | 3 | 1–10 | x | ||||
3 | M | 25 | 9 | 0 | x | ||||
4 | F | 38 | 0 | 101–500 | x | ||||
5 | F | 48 | 11–50 | 1000+ | x | ||||
6 | F | 26 | 0 | 11–50 | x | ||||
7 | F | 45 | 51–100 | 101–500 | 81 | ||||
8 | F | 66 | 15 | 11–50 | 22 | ||||
9 | M | 48 | 0 | 11–50 | 39 | ||||
10 | M | 44 | 0 | 1000+ | 28 | ||||
11 | F | 55 | 11–50 | 101–500 | 44 | ||||
12 | M | 41 | 0 | 11–50 | 16 | ||||
13 | M | 42 | 0 | 11–50 | 22 | ||||
14 | M | 45 | 0 | 51–100 | 74 | ||||
15 | M | 21 | 0 | 11–50 | 38 | ||||
16 | M | 27 | 11–50 | 11–50 | 61 | ||||
17 | F | 42 | 0 | 1000+ | 76 | ||||
18 | F | 53 | 0 | 1000+ | 341 | ||||
19 | M | 23 | 2 | 500+ | 119 | ||||
20 | M | 25 | 0 | 11–50 | 476 | ||||
21 | F | 36 | 11–50 | 51–100 | 326 | x | |||
22 | F | 49 | 11–50 | 51–100 | 382 | ||||
23 | F | 26 | 0 | 11–50 | 491 | ||||
24 | M | 31 | 0 | 11–50 | 212 | ||||
25 | M | 47 | 11–50 | 1000+ | 115 | ||||
26 | F | 35 | 8 | 11–50 | 112 | ||||
27 | M | 26 | 1000+ | 1000+ | 739 | x | |||
28 | F | 54 | 0 | 1000+ | 900 | ||||
29 | F | 24 | 0 | 0 | 810 | ||||
30 | M | 31 | 10–500 | 7 | 5408 | ||||
31 | F | 20 | 1000+ | 11–50 | 950 | ||||
32 | F | 50 | 51–100 | 1000+ | 1191 | ||||
33 | F | 34 | 0 | 101–500 | 508 | ||||
34 | M | 41 | 9 | 1000+ | 577 | ||||
35 | M | 43 | 0 | 8 | 661 | ||||
36 | F | 62 | 11–50 | 51–100 | 1005 | ||||
37 | M | 49 | 0 | 51–100 | 767 |
* Volume below detection level (1 cm3)